دورية أكاديمية
A new dosing regimen of ropeginterferon alfa-2b is highly effective and tolerable: findings from a phase 2 study in Chinese patients with polycythemia vera
| العنوان: | A new dosing regimen of ropeginterferon alfa-2b is highly effective and tolerable: findings from a phase 2 study in Chinese patients with polycythemia vera |
|---|---|
| المؤلفون: | Jin, JieAff1, IDs40164023004150_cor1, Zhang, LeiAff2, IDs40164023004150_cor2, Qin, AlbertAff3, IDs40164023004150_cor3, Wu, Daoxiang, Shao, Zonghong, Bai, Jie, Chen, Suning, Duan, Minghui, Zhou, Hu, Xu, Na, Zhang, Sujiang, Zuo, Xuelan, Du, Xin, Wang, Li, Li, Pei, Zhang, Xuhan, Li, Yaning, Zhang, Jingjing, Wang, Wei, Shen, Weihong, Zagrijtschuk, Oleh, Urbanski, Raymond, Sato, Toshiaki, Xiao, Zhijian |
| المصدر: | Experimental Hematology & Oncology. 12(1) |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 21623619 |
|---|---|
| DOI: | 10.1186/s40164-023-00415-0 |